🟢 NeOnc Technologies Holdings is trading 5% up in pre-market on continued momentum from positive NEO100 data

NeOnc Technologies Holdings is trading at $5.21, up +5.04%, amid continued momentum following positive NEO100 Phase 2a data.

• No new company-specific announcement or material filing was identified for September 3, 2026.
• Six-month progression-free survival reached 48.9%, versus a 20% benchmark.
• Coverage describes the advance as ongoing momentum and a technical breakout, not a discrete fresh catalyst.